Defence Therapeutics's total assets for Q1 2024 were C$424.67K, a decrease of -11.11% from the previous quarter. DTCFF total liabilities were C$4.55M for the fiscal quarter, a 11.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.